Solu
2 known investors
Solu provides a cloud-based genomic surveillance platform that analyzes microbial genomes in real-time without requiring coding or configuration. The platform serves public health institutions, research labs, and medical centers performing pathogen sequencing, outbreak detection, and antimicrobial resistance monitoring.
BiotechCloud ComputingHealthtech
Investors · 2
In the news
- Boston biotech Solu raises $41M Series Aaxios.com · 2025
- Solu Therapeutics Secures $41M for Hematologic Advancestechnews180.com · 2025
- Solu Therapeutics Closes $41M Series A Financingfinsmes.com · 2025
- Solu Therapeutics Raises $31M in Seed Fundingfinsmes.com · 2023
- Finnish biotech startup Solu raises €1M to combat global antibiotic resistancelabiotech.eu · 2023
- Solu Raises $1.3M in Seed Funding - FinSMEsfinsmes.com · 2015